ES8105996A1 - Un procedimiento para la preparacion de 4-(tiazolil sustituido)-3-hidroxi-3-pinrolin 2,5.dionas inhibodoras de la acido glicolico oxidasa. - Google Patents

Un procedimiento para la preparacion de 4-(tiazolil sustituido)-3-hidroxi-3-pinrolin 2,5.dionas inhibodoras de la acido glicolico oxidasa.

Info

Publication number
ES8105996A1
ES8105996A1 ES494933A ES494933A ES8105996A1 ES 8105996 A1 ES8105996 A1 ES 8105996A1 ES 494933 A ES494933 A ES 494933A ES 494933 A ES494933 A ES 494933A ES 8105996 A1 ES8105996 A1 ES 8105996A1
Authority
ES
Spain
Prior art keywords
hidroxi
substituted
procedure
formula
glycolic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES494933A
Other languages
English (en)
Other versions
ES494933A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of ES8105996A1 publication Critical patent/ES8105996A1/es
Publication of ES494933A0 publication Critical patent/ES494933A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE 4-(TIAZOLIL SUSTITUIDO)-3-HIDROXI-3-PIRROLIN-2,5-DIONAS, INHIBIDORAS DE LA ACIDO GLICOLICO-OXIDASA, DE FORMULA (I), Y DE SUS SALES FARMACOLOGICAMENTE COMPATIBLES, EN LA QUE R1, R2 Y R3 PUEDEN SER VARIOS TIPOS DE RADICALES, "M" VALE DE 0 A 3 Y "N" DE 0 A 2, Y DE MODO QUE LOS SUSTITUYENTES SOBRE ANILLO TIAZOLILO NO SEAN ADYACENTES. SE BASA EN LA REACION DE UN COMPUESTO DE FORMULA (II), EN LA QUE W ES -CONH2 Y "N" VALE 0 O W ES -CN Y "N" VALE 0 A 2, CON OXALATO DE DIETILO EN PRESENCIA DE T-BUTOXIDO DE POTASIO O ETOXIDO SODICO EN DIMETILFORMAMIDA O DE ALCOXIDOS EN DISOLVENTES ALCOHOLICOS. SI W ES -CN, SE TRATA A CONTINUACION CON ACIDO EN MEDIO ALCOHOLICO Y SE CALIENTA LA MEZCLA PARA OBTENER LA CICLACION EL PRODUCTO. ESTE SE PUEDE HACER REACCIONAR CON UNA BASE ORGANICA O INORGANICA PARA OBTENER LA SAL CORRESPONDIENTE. ESTOS COMPUESTOS SON UTILES EN EL TRATAMIENTO Y PREVENCION DE PADECIMIENTOS DE CALCULOS DE OXALATO CALCICO EN EL RIÑON Y EN LA VEJIGA. *FORMULA*
ES494933A 1979-09-11 1980-09-10 Un procedimiento para la preparacion de 4-(tiazolil sustituido)-3-hidroxi-3-pinrolin 2,5.dionas inhibodoras de la acido glicolico oxidasa. Granted ES494933A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/074,465 US4298743A (en) 1979-09-11 1979-09-11 4-(Substituted phenyl thiazolyl)-3-hydroxy-3-pyrroline-2,5-diones

Publications (2)

Publication Number Publication Date
ES8105996A1 true ES8105996A1 (es) 1981-07-01
ES494933A0 ES494933A0 (es) 1981-07-01

Family

ID=22119703

Family Applications (1)

Application Number Title Priority Date Filing Date
ES494933A Granted ES494933A0 (es) 1979-09-11 1980-09-10 Un procedimiento para la preparacion de 4-(tiazolil sustituido)-3-hidroxi-3-pinrolin 2,5.dionas inhibodoras de la acido glicolico oxidasa.

Country Status (9)

Country Link
US (1) US4298743A (es)
EP (1) EP0025232B1 (es)
JP (1) JPS5646809A (es)
AT (1) ATE2271T1 (es)
DE (1) DE3061688D1 (es)
DK (1) DK384280A (es)
ES (1) ES494933A0 (es)
GR (1) GR70200B (es)
PT (1) PT71755B (es)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4379791A (en) * 1979-09-11 1983-04-12 Merck & Co., Inc. 4-(Substituted thiazolyl)-3-hydroxy-3-pyrroline-2,5-dione inhibitors of glycolic acid oxidase
US4700901A (en) * 1985-08-19 1987-10-20 Breville R & D Pty. Limited Food processors
CA2074933C (en) * 1990-11-30 2002-12-03 Masatoshi Chihiro Thiazole derivatives as active superoxide radical inhibitors
MY128323A (en) * 1996-09-30 2007-01-31 Otsuka Pharma Co Ltd Thiazole derivatives for inhibition of cytokine production and of cell adhesion
US6313156B1 (en) 1999-12-23 2001-11-06 Icos Corporation Thiazole compounds as cyclic-AMP-specific phosphodiesterase inhibitors
DE10029077A1 (de) 2000-06-13 2001-12-20 Bayer Ag Thiazolylsubstituierte Heterocyclen
DK3042894T1 (da) * 2001-08-10 2016-11-07 Shionogi & Co Antiviralt middel
US6858615B2 (en) 2002-02-19 2005-02-22 Parion Sciences, Inc. Phenyl guanidine sodium channel blockers
US6858614B2 (en) 2002-02-19 2005-02-22 Parion Sciences, Inc. Phenolic guanidine sodium channel blockers
US7202257B2 (en) 2003-12-24 2007-04-10 Deciphera Pharmaceuticals, Llc Anti-inflammatory medicaments
US7144911B2 (en) 2002-12-31 2006-12-05 Deciphera Pharmaceuticals Llc Anti-inflammatory medicaments
US7279576B2 (en) 2002-12-31 2007-10-09 Deciphera Pharmaceuticals, Llc Anti-cancer medicaments
US6903105B2 (en) 2003-02-19 2005-06-07 Parion Sciences, Inc. Sodium channel blockers
US7745442B2 (en) 2003-08-20 2010-06-29 Parion Sciences, Inc. Methods of reducing risk of infection from pathogens
WO2006071940A2 (en) 2004-12-23 2006-07-06 Deciphera Pharmaceuticals, Llc Enzyme modulators and treatments
US8188113B2 (en) 2006-09-14 2012-05-29 Deciphera Pharmaceuticals, Inc. Dihydropyridopyrimidinyl, dihydronaphthyidinyl and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
US7790756B2 (en) 2006-10-11 2010-09-07 Deciphera Pharmaceuticals, Llc Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
CA2684950A1 (en) 2007-04-20 2008-10-30 Deciphera Pharmaceuticals, Llc Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
CN102256493A (zh) 2008-10-29 2011-11-23 迪赛孚尔制药有限公司 表现出抗癌活性和抗增殖活性的环丙烷酰胺及其类似物
AR086745A1 (es) 2011-06-27 2014-01-22 Parion Sciences Inc 3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil)carbamimidoil)pirazina-2-carboxamida
US8461179B1 (en) 2012-06-07 2013-06-11 Deciphera Pharmaceuticals, Llc Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
PE20151054A1 (es) 2012-12-17 2015-08-07 Parion Sciences Inc Derivados de cloro-pirazin carboxamida con actividad bloqueadora sobre los canales de sodio epiteliales
MX2015007797A (es) 2012-12-17 2015-10-05 Parion Sciences Inc Compuestos de 3,5-diamino-6-cloro-n-(n-(4-fenilbutil) carbamimidoil) pirazin-2-carboxamida.
US9102633B2 (en) 2013-12-13 2015-08-11 Parion Sciences, Inc. Arylalkyl- and aryloxyalkyl-substituted epithelial sodium channel blocking compounds
EP3746059B1 (en) 2018-01-31 2026-03-04 Deciphera Pharmaceuticals, LLC Combination therapy for the treatment of gastrointestinal stromal tumors
AU2019216351B2 (en) 2018-01-31 2024-07-25 Deciphera Pharmaceuticals, Llc Combination therapy for the treatment of mastocytosis
WO2020185812A1 (en) 2019-03-11 2020-09-17 Teva Pharmaceuticals International Gmbh Solid state forms of ripretinib
FI4013412T3 (fi) 2019-08-12 2026-03-24 Deciphera Pharmaceuticals Llc Ripretinibi ruoansulatuskanavan stroomakasvaimien hoitoon
TWI878335B (zh) 2019-08-12 2025-04-01 美商迪賽孚爾製藥有限公司 治療胃腸道基質瘤方法
AU2020419197B2 (en) 2019-12-30 2023-08-31 Deciphera Pharmaceuticals, Llc Amorphous kinase inhibitor formulations and methods of use thereof
PL4084779T3 (pl) 2019-12-30 2025-02-24 Deciphera Pharmaceuticals, Llc Kompozycje 1-(4-bromo-5-(1-etylo-7-(metyloamino)-2-okso-1,2-dihydro-1,6-naftyrydyn-3-ylo)-2-fluorofenylo)-3-fenylomocznika
US11779572B1 (en) 2022-09-02 2023-10-10 Deciphera Pharmaceuticals, Llc Methods of treating gastrointestinal stromal tumors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE599556A (es) * 1960-02-01
US3340263A (en) * 1964-02-14 1967-09-05 Ciba Geigy Corp Amino-pyrroles
GB1127875A (en) * 1967-03-23 1968-09-18 Parke Davis & Co 4-(5-nitro-2-furyl) thiazolyl hydantoins and hydrouracils
GB1304174A (es) * 1969-03-07 1973-01-24

Also Published As

Publication number Publication date
DE3061688D1 (en) 1983-02-24
DK384280A (da) 1981-03-12
ATE2271T1 (de) 1983-02-15
PT71755A (en) 1980-09-01
EP0025232A1 (en) 1981-03-18
JPS5646809A (en) 1981-04-28
ES494933A0 (es) 1981-07-01
PT71755B (en) 1982-03-19
GR70200B (es) 1982-08-31
US4298743A (en) 1981-11-03
EP0025232B1 (en) 1983-01-19

Similar Documents

Publication Publication Date Title
SE8001099L (sv) Beta-laktamforeningar
BG101422A (bg) Бензоксазолни производни като бронхоразширяващи средства
BR8807266A (pt) Compostos heterociclicos
ES8704872A1 (es) Un procedimiento para preparar aril-hidroxamatos
TW368501B (en) 7-(2-aminoethyl)-benzothiazolones
ES8603497A1 (es) Procedimiento para preparar derivados de cefalosporina
RO81943B (ro) Procedeu de preparare a unor derivati de piridoxina
SE7611047L (sv) Forfarande for framstellning av antibakteriella emnen
ES8306751A1 (es) Un procedimiento para la preparacion de 2-guanidino-4-heteroariltiazoles.
GT200200146A (es) Nuevos compuestos fungicidas
BG60338B2 (en) Thienothiazines
ES8301976A1 (es) Un procedimiento para la preparacion de derivados de oxazolidin-2,4-diona 5-heterociclico sustituidos.
FI101301B1 (fi) Menetelmä terapeuttisesti käyttökelpoisten, N-substituoitujen heksahydroatsepiinijohdannaisten valmistamiseksi
FI812650L (fi) Extraktionsfoerfarande foer selektiv avlaegsning av kobolt (ii) ur vattenhaltiga loesningar
GB1095784A (en) Benzothioxanthene dyestuffs and processes for their manufacture
ATE33133T1 (de) Alpha-alkyl-polyencarbonsaeuren, ihre derivate und ihre verwendung in der behandlung von psoriasis.
ES8601209A1 (es) Procedimiento para preparar derivados de 5h-(1)-benzopirano-(2,3-d)pirimidina
FI871316A0 (fi) Foerfarande foer framstaellning av acymmetriska esterderivat av 1,4-dihydropyridin-3,5-dikarboxylsyra.
GB1038735A (en) New condensed heterocyclic compounds, their production and compositions containing them
SE8206923L (sv) Azolyl-penten-derivat, forfarande for framstellning av dessa foreningar samt biocida medel innehallande dem
ES2105596T3 (es) Procedimiento para la preparacion de un acido oxazolidina-1,3-carboxilico-5.
GB989557A (en) Hydroxylamine derivative and processes for making it
SE8305594D0 (sv) 2-fenoxipropionsyraderivat av pentiten, forfaranden for framstellning av dess foreningar samt medel innehallande dem med herbicid verkan
ATE24722T1 (de) Neue saeure-derivate, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung von mikroorganismen.
ATE2076T1 (de) Verfahren zur herstellung von 5-(2,2,2-